11.30
Amneal Pharmaceuticals Inc Aktie (AMRX) Neueste Nachrichten
Implied Volatility Surging for Amneal Pharmaceuticals Stock Options - TradingView
Will Amneal Pharmaceuticals Inc. stock outperform Dow Jones index2025 Historical Comparison & Stock Market Timing Techniques - newser.com
Real time breakdown of Amneal Pharmaceuticals Inc. stock performanceJuly 2025 Analyst Calls & Free Long-Term Investment Growth Plans - newser.com
Is Amneal Pharmaceuticals Inc. stock in correction or buying zonePortfolio Return Report & Weekly Breakout Stock Alerts - newser.com
Is Amneal Pharmaceuticals Inc. stock ready for a breakoutWeekly Trade Recap & Intraday High Probability Alerts - newser.com
Multi asset correlation models including Amneal Pharmaceuticals Inc.Quarterly Trade Review & AI Driven Stock Movement Reports - newser.com
BioSpace 2026 Best Places to Work Spotlights Most Desirable Workplaces - BioSpace
Candlestick signals on Amneal Pharmaceuticals Inc. stock todayJuly 2025 Movers & Daily Stock Trend Reports - newser.com
Will Amneal Pharmaceuticals Inc. stock benefit from automationJuly 2025 Earnings & Fast Moving Stock Watchlists - newser.com
How high can Amneal Pharmaceuticals Inc. stock goInsider Buying & Weekly Watchlist for Consistent Profits - newser.com
What analyst consensus says on Amneal Pharmaceuticals Inc. stockWeekly Trend Summary & Community Consensus Stock Picks - newser.com
Is Amneal Pharmaceuticals Inc. stock resilient to inflationPortfolio Risk Report & Weekly Chart Analysis and Trade Guides - newser.com
Is Amneal Pharmaceuticals Inc. stock a top momentum play2025 Trading Volume Trends & Real-Time Market Trend Scan - newser.com
Does Amneal Pharmaceuticals Inc. show high probability of rebound2025 Technical Overview & Real-Time Stock Movement Alerts - newser.com
Will Amneal Pharmaceuticals Inc. stock reach Wall Street targetsEarnings Risk Summary & Risk Controlled Swing Trade Alerts - newser.com
How to manage a losing position in Amneal Pharmaceuticals Inc.Weekly Investment Report & Verified Stock Trade Ideas - newser.com
Published on: 2025-11-02 12:06:47 - newser.com
Amneal Pharmaceuticals Reports Strong Q3 2025 Results - MSN
Amneal Pharmaceuticals Hits New 52-Week High of $10.70 - Markets Mojo
Piper Sandler Reaffirms Overweight Rating for Amneal Pharmaceuticals (NASDAQ:AMRX) - MarketBeat
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB), Option Care Health (OPCH) and Amneal Pharmaceuticals (AMRX) - The Globe and Mail
Amneal raises 2025 EPS guidance and outlines $300M–$500M CREXONT sales target as portfolio expansion accelerates - MSN
Amneal Pharmaceuticals (AMRX) Receives a Buy from Truist Financial - The Globe and Mail
Amneal Pharmaceuticals stock hits 52-week high at $10.72 By Investing.com - Investing.com Australia
Amneal Pharmaceuticals (AMRX): One-Off $55.9M Loss Tests Bull Case Built on High Earnings Growth Forecasts - Sahm
Amneal Pharmaceuticals, Inc. (AMRX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Amneal Pharmaceuticals (NASDAQ:AMRX) Releases Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
Why Amneal (AMRX) Stock Is Up Today - Yahoo Finance
Amneal Pharmaceuticals (NASDAQ:AMRX) Reaches New 12-Month High on Strong Earnings - MarketBeat
Amneal Pharmaceuticals stock hits 52-week high at $10.72 - Investing.com
Truist Raises Price Target on Amneal Pharmaceuticals to $14 From $13, Keeps Buy Rating - MarketScreener
Amneal Pharmaceuticals (NASDAQ:AMRX) Updates FY 2025 Earnings Guidance - MarketBeat
Published on: 2025-10-31 02:59:36 - newser.com
Amneal Pharmaceuticals (AMRX) Profitability Milestone Tests Investor Optimism on Growth and Valuation - Yahoo Finance
Amneal Pharmaceuticals Q3 2025 Earnings Preview - MSN
Amneal: Q3 Earnings Snapshot - CT Insider
Amneal Pharmaceuticals Inc (AMRX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Amneal Q3 2025 slides: Revenue up 12% as specialty products gain traction - Investing.com Canada
How Amneal Pharmaceuticals’ (AMRX) Return to Profitability and Respiratory Product Wins Have Changed Its Investment Story - simplywall.st
Amneal raises 2025 guidance and targets $300M–$500M peak CREXONT sales as new launches accelerate - MSN
Earnings call transcript: Amneal Pharma Q3 2025 beats EPS forecast, stock rises - Investing.com
Amneal Pharmaceuticals, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:AMRX) 2025-10-30 - Seeking Alpha
Amneal (AMRX) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
Amneal Pharmaceuticals Q3 2025 Earnings Call Transcript - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):